CA
CVS icon

CGN Advisors’s CVS Health CVS Stock Holding History

CGN Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,576
Closed -$211K – 278
2024
Q2 		$211K Sell
3,576
-24,874
-87% -$1.56M 0.02% 259
2024
Q1 		$2.27M Buy
28,450
+328
+1% +$25.1K 0.29% 90
2023
Q4 		$2.22M Sell
28,122
-5,845
-17% -$416K 0.31% 97
2023
Q3 		$2.37M Buy
33,967
+1,610
+5% +$114K 0.32% 87
2023
Q2 		$2.24M Buy
32,357
+7,329
+29% +$521K 0.32% 87
2023
Q1 		$1.86M Buy
25,028
+5,922
+31% +$497K 0.29% 93
2022
Q4 		$1.78M Buy
19,106
+6,561
+52% +$633K 0.31% 89
2022
Q3 		$1.2M Buy
12,545
+3,822
+44% +$378K 0.3% 92
2022
Q2 		$808K Buy
8,723
+1,486
+21% +$145K 0.23% 119
2022
Q1 		$732K Buy
7,237
+406
+6% +$42.7K 0.18% 113
2021
Q4 		$705K Buy
6,831
+98
+1% +$9.06K 0.18% 118
2021
Q3 		$571K Buy
6,733
+450
+7% +$37.7K 0.19% 123
2021
Q2 		$524K Buy
6,283
+67
+1% +$5.49K 0.17% 132
2021
Q1 		$468K Buy
6,216
+307
+5% +$22.4K 0.17% 127
2020
Q4 		$404K Buy
+5,909
New +$384K 0.16% 127

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

CGN Advisors's CVS Position: Q3 2024 in Review

CGN Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,576 shares — an estimated $211K sold.

CGN Advisors first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $2.37M in Q3 2023. 1,843 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • CGN Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • CGN Advisors sold 3,576 CVS Health shares in Q3 2024, an estimated $211K.
  • CGN Advisors first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
  • CGN Advisors's CVS Health position peaked at $2.37M in Q3 2023.
  • 1,843 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on CGN Advisors's 13F filing for Q3 2024, filed 17 Oct 2024.